Home NDC 63481-815 Opana
Product NDC 63481-815
11-digit product format 634810815
Labeler code 63481
Product ID 63481-815_a9737e83-4dc5-4189-9100-dd1612d83191
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name oxymorphone hydrochloride
Dosage form TABLET, EXTENDED RELEASE
Route ORAL
Labeler Endo Pharmaceuticals Inc.
Application NDA201655
Marketing category NDA
Marketing start 2012-03-20
Marketing end 2020-01-01
Substance OXYMORPHONE HYDROCHLORIDE
Active strength 15 mg/1
Pharmacologic classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule CII
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N201655-001 OPANA ER OXYMORPHONE HYDROCHLORIDE 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-002 OPANA ER OXYMORPHONE HYDROCHLORIDE 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-003 OPANA ER OXYMORPHONE HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-004 OPANA ER OXYMORPHONE HYDROCHLORIDE 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-005 OPANA ER OXYMORPHONE HYDROCHLORIDE 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-006 OPANA ER OXYMORPHONE HYDROCHLORIDE 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 N201655-007 OPANA ER OXYMORPHONE HYDROCHLORIDE 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09
Orange Book patents# Current patent rows page 1 of 1 · 21 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 308 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-006 OPANA ER 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N201655-007 OPANA ER 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-006 OPANA ER 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201655-007 OPANA ER 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-006 OPANA ER 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201655-007 OPANA ER 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-006 OPANA ER 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201655-007 OPANA ER 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-006 OPANA ER 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201655-007 OPANA ER 40MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N201655-001 OPANA ER 5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201655-002 OPANA ER 7.5MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201655-003 OPANA ER 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201655-004 OPANA ER 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201655-005 OPANA ER 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2011-12-09 6a471c1ec25d…
Observed Orange Book patent history# Patent history page 1 of 53 · 2,114 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OXYMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT 5Y2EI94NBC OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 OXYMORPHONE ACTIVE MOIETY 9VXA968E0C OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 .ALPHA.-TOCOPHEROL INACTIVE INGREDIENT H4N855PNZ1 OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 TALC INACTIVE INGREDIENT 7SEV7J4R1U OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ENDO PHARMACEUTICALS INC.] 13